Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.
about
Precursors in cancer epidemiology: aligning definition and functionA unified set of analysis tools for uterine cervix image segmentation.DNA detection and seroprevalence of human papillomavirus in a cohort of adolescent women.Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection.A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.An evaluation by midwives and gynecologists of treatability of cervical lesions by cryotherapy among human papillomavirus-positive women.Elevated systemic levels of inflammatory cytokines in older women with persistent cervical human papillomavirus infection.A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection.Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycleChlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohortIncreased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection.Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young women.Clustering of multiple human papillomavirus infections in women from a population-based study in Guanacaste, Costa Rica.Switch from cytology-based to human papillomavirus test-based cervical screening: implications for colposcopy.Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting.Alterations of T-cell surface markers in older women with persistent human papillomavirus infection.Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican populationLong-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.Elevated methylation of HPV16 DNA is associated with the development of high grade cervical intraepithelial neoplasia.Evaluation of two types of sponges used to collect cervical secretions and assessment of antibody extraction protocols for recovery of neutralizing anti-human papillomavirus type 16 antibodies.The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women.Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa RicaCervical Cancer Screening for the Reluctant - HPV Testing of Air-Dried Vaginal Discharge.HPV16 CpG methyl-haplotypes are associated with cervix precancer and cancer in the Guanacaste natural history study.Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years.Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections.Comparison of ophthalmic sponges for measurements of immune markers from cervical secretionsRationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica.Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort.Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study.Treatability by cryotherapy in a screen-and-treat strategy.Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness Analysis.A comparison of cervical and vaginal human papillomavirus.High load for most high risk human papillomavirus genotypes is associated with prevalent cervical cancer precursors but only HPV16 load predicts the development of incident disease.Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-Year follow-up of the Guanacaste cohort.[Prophylactic and therapeutic HPV immunization].T cell receptor repertoire among women who cleared and failed to clear cervical human papillomavirus infection: An exploratory proof-of-principle study.
P2860
Q28387064-E5DDF0CA-D94B-403B-8EC1-EEFDFB5BB8A6Q33590357-6A909BBC-5CA5-48A5-B73A-CFF748E943D5Q33665786-8A9BD64F-CBF0-4C05-84DE-549DDEDFB9FBQ33698774-4918D007-B6B7-4F7B-8E20-D7D094E56B53Q33793914-F8195926-C0A0-48F6-8983-AC05034E018EQ33902505-28BE12BA-A7B6-41E3-B17F-BCB649845BC0Q34057798-7FAA5576-AE71-41E9-8534-3C208463AA25Q34153680-5D743F4B-EF72-4DE8-97B1-4770B803934AQ34154315-60E0CFFE-4821-44F4-89B0-535175B3AC19Q34366883-27B7FA59-3EB6-41DA-8B14-7205FB634439Q34553461-B96CEF3B-9ECA-4B19-9E69-CCCADDC874ECQ34763988-7DBD38A3-6212-4DAA-BFDC-C20041F69119Q34959801-198F658A-0321-4A8C-A404-2285F27C71B7Q35093306-89143B4F-FB1C-402C-8130-0075EF1856DAQ35182177-E83C2B88-E6A5-49F6-B51A-D4C0BC456C3AQ35669010-F4336AAC-167D-42C2-B842-527F5BB1E83AQ35778017-4418C20A-C7CB-47E4-8634-685F4CEDD1C5Q35866379-00D23696-E64F-44BA-A26F-45D5E3E43A0CQ35907158-2A353A39-3E58-47F5-9FED-90BCF9EE7FCEQ35974650-13E53D99-5BEC-4CF1-8387-1EFD9AA9BB14Q36385102-C6A21221-C5E6-43E9-B6FD-CFC93AFDE137Q36422593-29899A0F-F84C-4B7B-9CF9-1DA4C4756699Q36615291-1F71E3D1-5B7E-4B62-AB43-0EA3714845E5Q36695693-7F390BB4-6BFE-4A0A-AEA3-D2E17662E8D5Q36735294-770F2967-3B27-469C-9F07-593232C0BDB1Q36901882-A0DEC7A8-D2FF-4728-A489-C7F4DA13E541Q36988499-A30F1D72-F7F3-4AB4-B36B-8D3BAFFFDD63Q36994715-7A67E033-03D5-4284-B714-6511747F975AQ37015180-A1BFD4C3-271A-412A-983C-D930CD30198CQ37120290-92AC635C-7AF2-4E92-8487-B840B81D3F13Q37195383-E27A3032-E60F-46CF-9E7D-F90600EE361EQ37281729-A6004D36-7E80-4578-AD25-BC7785DC9EB9Q37328029-5978F65A-13BA-44A4-8E57-6755BC795666Q37398007-CB778F31-65E2-417A-93AC-387B5E2DD0DBQ37407506-5FC1DC40-C79A-4328-82B5-5D398937C77DQ37656614-1E979B32-0637-4FE6-8BD8-036D826E54FBQ37656990-3913D581-B712-4D6F-AB40-5CE76424B823Q40359221-3C689DEF-6007-4C12-897A-8161F9EDDBD7Q44356028-957A354F-40A9-406C-AC72-9CD26540FC3AQ48133769-5D3BFE83-8C0E-4019-97A4-C5FDD9E0057E
P2860
Description of a seven-year prospective study of human papillomavirus infection and cervical neoplasia among 10000 women in Guanacaste, Costa Rica,.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Description of a seven-year pr ...... en in Guanacaste, Costa Rica,.
@en
type
label
Description of a seven-year pr ...... en in Guanacaste, Costa Rica,.
@en
prefLabel
Description of a seven-year pr ...... en in Guanacaste, Costa Rica,.
@en
P2093
P1476
Description of a seven-year pr ...... en in Guanacaste, Costa Rica,.
@en
P2093
Allan Hildesheim
Ana C Rodríguez
Claire Eklund
Diego Guillén
Elmer Pérez
Fernando Cárdenas
John Schussler
Jorge Morales
Julie Buckland
Lidia A Morera
P356
10.1590/S1020-49892004000200002
P577
2004-02-01T00:00:00Z